Edition:
United States

Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.31USD
2 Dec 2016
Change (% chg)

$-0.25 (-44.59%)
Prev Close
$0.56
Open
$0.42
Day's High
$0.44
Day's Low
$0.29
Volume
8,951,320
Avg. Vol
251,825
52-wk High
$1.06
52-wk Low
$0.29

PLX

Chart for PLX

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.57
Market Cap(Mil.): ₪185.64
Shares Outstanding(Mil.): 99.93
Dividend: --
Yield (%): --

Financials

  PLX Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -1.37 -- --
ROI: -72.58 -1.09 14.95
ROE: -- -2.39 16.29

Earnings vs. Estimates